A “micro-tap” for treating glaucoma

Share via AddThis
Posted March 26, 2013

A tiny, EPFL-designed implantable device that can be positioned within the eye and controlled remotely may well revolutionize the treatment of glaucoma. The device should be through testing this year and on its way to the market in 2014 via Rheon Medical, an EPFL spin-off.

Glaucoma is the second leading cause of blindness globally, after cataracts. It is characterized by the presence of too much liquid between the cornea and the iris. This leads to a build-up of pressure within the eye, a situation that can destroy the optic nerve if it is not handled correctly.

Read more at: EPFL

47,211 science & technology articles


Our Articles (see all)

General News

Follow us

Facebook   Twitter   Pinterest   StumbleUpon   Plurk
Google+   Tumblr   Delicious   RSS   Newsletter via Email

Featured Video (see all)

Ready-to-use robotics development kit
SentiBotics is a ready-to-use robotic kit designed to provide a starting point for researchers and developers, who would…

Featured Image (see all)

Staphylococcus aureus being phagocytized
Produced by the National Institute of Allergy and Infectious Diseases (NIAID), this digitally-colorized scanning electron micrograph (SEM) depicts…